Equity · Healthcare
MGX
NASDAQMetagenomi (MGX)
The line runs 1.22 USD on 3 August through 0.786 USD on 30 October, on a scale from 0.6 to 1.4. Days the market did not trade hold the previous close, flat.
- Market cap
- 29.7M USD
- Revenue, year to Dec 2025
- 25.2M USD
- EPS, diluted, year to Dec 2025
- −2.36 USD
- 52-week range
- 0.7662 USD – 2.90 USD
- Avg volume
- 4.1K
- Mentions, 30 days
- 3
as of Oct 30, 2026
Have Metagenomi (MGX) insiders bought or sold shares recently?
In the 90 days to 31 Oct 2026, Metagenomi insiders reported 3 open-market sales and 1 purchase (SEC Form 4).
Form 4, 90 days to 31 Oct 2026, newest reported trade 9 Sep 2026
Buys 1Sells 3Net bought $18KOther filings 0
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 09 Sep 2026 | Reid LaurenceDirector | Buy | 20,000 | 23K USD |
| 08 Sep 2026 | Wein MatthewSee Remarks | Sell | 358 | 415 USD |
| 08 Sep 2026 | Irish JianSee Remarks | Sell | 2,140 | 2K USD |
| 08 Sep 2026 | Wapnick PamelaChief Financial Officer | Sell | 1,911 | 2K USD |
| Bought | 1 open-market purchase | 20,000 | $23K | |
| Sold | 3 open-market sales | 4,409 | $5K |
Which funds hold Metagenomi (MGX)?
5 of the 45 institutional funds we track reported a Metagenomi position for the quarter ended 30 Jun 2026 — a combined 1.8M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Held (±25%) | 742,400 | 883K USD | −5.8% |
| Two Sigma Investments | Held (±25%) | 513,701 | 611K USD | +3.4% |
| Millennium Management | Trimmed | 114,025 | 136K USD | −33.0% |
| Man Group | Added | 109,130 | 130K USD | +38.8% |
| Citadel Advisors | Held (±25%) | 17,851 | 21K USD | +5.0% |
| Marshall Wace | Exited | |||
| Point72 Asset Management | Exited |
What has been filed or recorded for Metagenomi (MGX)?
The filings we hold for Metagenomi, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,997 shares | 2K USD notional · 0.005% of shares out |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 3 shares | 3 USD notional · <0.001% of shares out |
| 18 Sep 2026 | Fails to deliver | Shares failed to deliver | 5,732 shares | 6K USD notional · 0.015% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.73 USD | |
| 30 Jun 2026 | Financials | Total assets | 173.7M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 112.6M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.61 USD | Revenue $1M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −2.36 USD | Revenue $25M |
| 31 Dec 2025 | Financials | Revenue | 25.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −87.9M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −2.36 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.55 USD | Revenue $9M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.54 USD | Revenue $9M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.68 USD | Revenue $4M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −2.36 USD | Revenue $52M |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −0.51 USD | Revenue $12M |
What is Reddit saying about Metagenomi (MGX)?
Reddit mentioned MGX 3 times in the 30 days to 31 October 2026, across 2 of the communities we track. All of them were scored for sentiment: 33% read bullish, 33% bearish and 34% neither. Reddit data updated 31 October 2026.
30-day window, Method
Mentions, 30 days 3Communities 2
How do Reddit mentions of Metagenomi (MGX) compare with its price?
Share ↗
Where Metagenomi (MGX) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/stocks | 67% | 2 | +0.20 |
| r/asx_bets | 33% | 1 | −0.33 |
Metagenomi (MGX): frequently asked questions
What did Metagenomi shares close at?
Metagenomi closed at 0.786 USD on 30 Oct 2026, down 4.17% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Metagenomi’s market cap?
Metagenomi is worth 29.7M USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Metagenomi’s revenue?
Metagenomi reported revenue of 25.2M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Metagenomi insiders bought or sold shares recently?
In the 90 days to 31 Oct 2026, Metagenomi insiders reported 3 open-market sales and 1 purchase (SEC Form 4). See Insiders
Which funds own Metagenomi?
5 of the 45 funds we track reported a Metagenomi position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, Two Sigma Investments and Millennium Management. See Funds
When did Metagenomi last report earnings?
Metagenomi last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.73 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Metagenomi?
Metagenomi was mentioned 0 times in the last 7 days across the finance subreddits we track, and 3 times over the trailing 30 days. Of the 3 mentions scored for sentiment, 33% read bullish and 33% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings